Jia Xin Yu

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Lacey Padrón, Deena M. Maurer, Mark H. O’Hara et al. · Nature Medicine · 2022 · 350 citations · Full text

Medicine, Oncology, Pharmacology +15

CRI iAtlas: an interactive portal for immuno-oncology research

James A. Eddy, Vésteinn Thórsson, Andrew Lamb et al. · F1000Research · 2020 · 71 citations · Full text

Medicine, Immunology, Oncology +17

RNA-Seq identifies SPGs as a ventral skeletal patterning cue in sea urchins

Michael L. Piacentino, Daniel T. Zuch, Julie Fishman et al. · Development · 2016 · 39 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +16

Targeting of <scp>CDKN</scp>1B by miR‐222‐3p may contribute to the development of intervertebral disc degeneration

Jianwei Liu, Jia Xin Yu, Weiping Jiang et al. · FEBS Open Bio · 2019 · 25 citations · Full text

Life Sciences, Molecular Biology, Apoptosis +13

Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC Polypharmacology

Jia Xin Yu, Amanda J. Craig, Mary E. Duffy et al. · Molecular Cancer Therapeutics · 2019 · 21 citations · Full text

Medicine, Oncology, Pharmacology +12